𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma

✍ Scribed by Friedberg, J W; Kim, H; Li, S; Neuberg, D; Boyd, K; Daley, H; Fisher, D C; Gribben, J G; Spitzer, T; Freedman, A S

Book ID
110013876
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
132 KB
Volume
32
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutic results in patients with rel
Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation
✍ Felicetto Ferrara; Assunta Viola; Carolina Copia; Ettore Mariano Schiavone; Mari πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Abstract Forty patients with relapsed diffuse large B cell lymphoma (DLBCL) autografted in partial response (PR) (__n__ = 23) or in refractory relapse (RR) (__n__ = 17) achieved complete remission (CR) after autologous stem cell transplantation (ASCT). Salvage treatment consisted of ifosphamide,

Successful long-term control with lamivu
Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: Experience of 2 cases
✍ Masashi Nakagawa; Yoshifumi Simizu; Masaki Suemura; Bunzo Sato πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 3 views

## Abstract It is well documented that cytotoxic treatment in patients carrying the hepatitis B virus (HBV) enhances the risk of severe hepatic damage. Recently lamivudine has been reported to be effective in suppressing the replication of HBV under such conditions. Here we report two cases with HB